Continuing, Stopping Immunosuppression Tested in Lupus Nephr

Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy.

Related Keywords

Milan , Lombardia , Italy , Copenhagen , Køavn , Denmark , France , French , Christophe Richez , Vifor Pharma , Noemie Jourde Chiche , Hospitalier Pellegrin , Ospedale Maggiore Policlinico , Glaxosmithkline , European Congress , Astrazeneca , Marseille France University , Novartis , Fresenius Medical Care , Groupe Hospitalier , Lupus Nephritis , Activity Index , Discontinuation Versus Continuation Not Shown , Fresenius Medical , Systemic Lupus Erythematosus , Sale , Lupus , End Stage Renal Disease Esrd , End Stage Renal Disease , Srd , Immunosuppressive Therapy , Immunosuppressive Agents , Immunosuppressive Drugs , Rug Immunosuppressive , Immunocompromise , Immunocompromised , Glucocorticosteroids , Kidneys , Neoadjuvant , Activism , Activist , Europe , European , Pregnancy , Remission , Social Issues ,